Boccon-Gibod I - Search Results

1

Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study.

Javaud N, Gompel A, Bouillet L, Boccon-Gibod I, Cantin D, Smaiti N, Carpentier F, Boubaya M, Launay D, Adnet F, Fain O. Javaud N, et al. Ann Allergy Asthma Immunol. 2015 Jun;114(6):499-503. doi: 10.1016/j.anai.2015.04.005. Epub 2015 Apr 29. Ann Allergy Asthma Immunol. 2015. PMID: 25935434

2

Disease expression in women with hereditary angioedema.

Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, Caballero T, Drouet C, Farkas H, Massot C, Nielsen EW, Ponard D, Cicardi M. Bouillet L, et al. Am J Obstet Gynecol. 2008 Nov;199(5):484.e1-4. doi: 10.1016/j.ajog.2008.04.034. Epub 2008 Jun 13. Am J Obstet Gynecol. 2008. PMID: 18554570

3

Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

Bouillet L, Boccon-Gibod I, Ponard D, Drouet C, Cesbron JY, Dumestre-Perard C, Monnier N, Lunardi J, Massot C, Gompel A. Bouillet L, et al. Ann Allergy Asthma Immunol. 2009 Nov;103(5):448. doi: 10.1016/S1081-1206(10)60369-9. Ann Allergy Asthma Immunol. 2009. PMID: 19927548 No abstract available.

4

Type III hereditary angio-oedema: clinical and biological features in a French cohort.

Vitrat-Hincky V, Gompel A, Dumestre-Perard C, Boccon-Gibod I, Drouet C, Cesbron JY, Lunardi J, Massot C, Bouillet L. Vitrat-Hincky V, et al. Allergy. 2010 Oct;65(10):1331-6. doi: 10.1111/j.1398-9995.2010.02368.x. Epub 2010 Apr 7. Allergy. 2010. PMID: 20384613

5

[Bradykinin mediated angioedema].

Bouillet L, Boccon-Gibod I, Massot C. Bouillet L, et al. Rev Med Interne. 2011 Apr;32(4):225-31. doi: 10.1016/j.revmed.2009.11.021. Epub 2010 Jun 9. Rev Med Interne. 2011. PMID: 20538389 French.

6

Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate.

Bouillet L, Boccon-Gibod I, Dumestre-Perard C, Cesbron JY, Massot C. Bouillet L, et al. Br J Dermatol. 2011 Jun;164(6):1406-7. doi: 10.1111/j.1365-2133.2011.10316.x. Br J Dermatol. 2011. PMID: 21410680 No abstract available.

7

[Management of bradykinin-mediated angioedema].

Floccard B, Crozon J, Rimmelé T, Vulliez A, Coppere B, Chamouard V, Boccon-Gibod I, Bouillet L, Allaouchiche B. Floccard B, et al. Ann Fr Anesth Reanim. 2011 Jul-Aug;30(7-8):578-88. doi: 10.1016/j.annfar.2011.01.011. Epub 2011 Mar 31. Ann Fr Anesth Reanim. 2011. PMID: 21454034 Review. French.

8

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B; HAWK (Hereditary Angioedema International Working Group). Cicardi M, et al. Allergy. 2012 Feb;67(2):147-57. doi: 10.1111/j.1398-9995.2011.02751.x. Epub 2011 Nov 30. Allergy. 2012. PMID: 22126399

9

Safety and efficacy of icatibant self-administration for acute hereditary angioedema.

Boccon-Gibod I, Bouillet L. Boccon-Gibod I, et al. Clin Exp Immunol. 2012 Jun;168(3):303-7. doi: 10.1111/j.1365-2249.2012.04574.x. Clin Exp Immunol. 2012. PMID: 22519593 Free PMC article.

10

Acquired C1-inhibitor deficiency: 7 patients treated with rituximab.

Branellec A, Bouillet L, Javaud N, Mekinian A, Boccon-Gibod I, Blanchard-Delaunay C, Oksenhendler E, Ollivier Y, Dunogué B, Amarger S, Ponard D, Drouet C, Mouthon L, Thomas M, Fain O; French National Reference Center for Angioedema (CREAK). Branellec A, et al. J Clin Immunol. 2012 Oct;32(5):936-41. doi: 10.1007/s10875-012-9691-2. Epub 2012 Apr 20. J Clin Immunol. 2012. PMID: 22526593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters